Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novartis MenACWY Conjugate Vaccine Consistency and Safety Study
NCT00450437Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal disease, sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00450437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450437.